Amanote Research
Register
Sign In
Pyrotinib Tops Lapatinib in Metastatic Breast Cancer
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2019-109
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
September 17, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib
AboutOpen
Q-TWiST Analysis of Lapatinib Combined With Capecitabine for the Treatment of Metastatic Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
BikDD Eliminates Breast Cancer Initiating Cells and Synergizes With Lapatinib for Breast Cancer Treatment
Cancer Cell
Cancer Research
Oncology
Cell Biology
Cutaneous Metastatic Breast Cancer
Clinical Journal of Oncology Nursing
Oncology
Symptom Management in Metastatic Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
A Phase II, Randomized, Multicenter Study Evaluating the Combination of Lapatinib and Vinorelbine in Women With ErbB2 Overexpressing Metastatic Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Metronomic Chemotherapy in Metastatic Breast Cancer
Novel Research in Sciences
Combination Chemotherapy in Metastatic Breast Cancer
BMJ
